NCT00079794已完成2 期
Iscar for Supplemental Care in Stage IV Lung Cancer
National Center for Complementary and Integrative Health (NCCIH)2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2001年9月最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 36
- 试验地点
- 2
研究概览
简要总结
The purpose of this study it to determine whether supplemental treatment with Iscar improves immune function and quality of life among Stage IV non-small cell lung carcinoma patients receiving conventional chemotherapy. Iscar is an herbal medicine made from the total plant extract of mistletoe. this preparation is already in use in Europe and its use in the US is likely to increase as cancer patients continue to seek alternative therapies.
详细描述
See Brief Summary
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Stage IV NSCLC patients who receive standard chemotherapy
- •Exclusion criteria:
- •Known allergy to Viscum Album L.
- •Concomitant use of other mistletoe products
- •Concomitant use of mushroom glucan and proteoglycan extracts
- •Concomitant use of thymus extract products
- •Inability to self-report quality of life utilizing assessment tools
- •Ongoing steroid or ACTH therapy
- •Co-morbid immunocompromised state
- •Pregnancy
- •Participation in other clinical trials
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Iscar for Second Line Treatment of Advanced Non-Small Cell Lung CancerNon-Small Cell Lung CancerNCT00283478Kentuckiana Cancer Institute20
已完成
2 期
Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung CancerLung CancerNCT00601796H. Lee Moffitt Cancer Center and Research Institute24
招募中
不适用
Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric CancerStage III Gastric CancerNCT05253716Jinling Hospital, China696
终止
1 期
Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung CancerLung Cancer, Non-Small CellNCT00455572GlaxoSmithKline71
终止
2 期
Combination of Chemoradiation With Immunotherapy in Inoperable œsophageal CancerInoperable œsophageal CancerNCT03437200European Organisation for Research and Treatment of Cancer - EORTC8